To understand these most aggressive and therapeutic-resistant GBM cells, we analyzed the role of HDAC2 in regulating cell death by inhibiting miR-3189-mediated GLUT3 in DOX-inducible shHDAC2 GSCs. The gene discussed is HDAC2; the disease is glioblastoma.